A bridge between interferon-alpha and tumor necrosis factor in lupus.
Aringer
Martin
M
Crow
Mary K
MK
D000962:Antimalarials / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D016898:Interferon-alpha / Q000276:immunology*; D016753:Interleukin-10 / Q000235:genetics / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology*; D048069:Tumor Necrosis Factors / Q000276:immunology*
D000962:Antimalarials; D016898:Interferon-alpha; D048069:Tumor Necrosis Factors; D016753:Interleukin-10